Floatz logo

70 assets in Prostate Neoplasm

Therapeutic assets addressing Prostate Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Jnj-75229414
Prostate Neoplasm
Janssen Research & Development, LLCP1CC (42)
Jnj-80038114
Prostate Neoplasm
Janssen Research & Development, LLCP1CC (42)
mk-5684
Prostate Neoplasm
Merck Sharp & Dohme LLCP1CC (42)
dm002
Prostate Neoplasm
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.P1C (39)
Immunoglobulin (H-Gamma1_L-Kappa)_Scfvkh-G1(H-Ch2-Ch3), Anti-[Homo Sapiens Klk2 (Kallikrein-2, Kallikrein Related Peptidase 2, Kallikrein 2 Prostatic) And Anti-[Homo Sapiens Cd3E (Cd3 Epsilon, Leu-4)], Homo Sapiens And Humanized Monoclonal Antibody, Bispecific, Bivalent
Prostate Neoplasm
Janssen Research & Development, LLCP1C (39)
Jnj-101556143
Prostate Neoplasm
Janssen Research & Development, LLCP1C (39)
Jnj-69086420
Prostate Neoplasm
Janssen Research & Development, LLCP1C (39)
Jnj-86974680
Prostate Neoplasm
Janssen Research & Development, LLCP1C (39)
Jnj-87189401
Prostate Neoplasm
Janssen Research & Development, LLCP1C (39)
Jnj-95298177
Prostate Neoplasm
Janssen Research & Development, LLCP1C (39)
(1R,3R)-N<sup>1</sup>-[5-(1-Ethylpropyl)pyrazolo[1,5-a]pyrimidin-7-yl]-1,3-cyclopentanediamine
Prostate Neoplasm
Nuvation Bio Inc.P1/2C (32)
Masofaniten
Prostate Neoplasm
Janssen Research & Development, LLCP1C (32)
68Ga-HTK03149
Prostate Neoplasm
British Columbia Cancer AgencyN/AD (30)
Propofol
Prostate Neoplasm
Yonsei UniversityN/AD (30)
Remimazolam
Prostate Neoplasm
Yonsei UniversityN/AD (30)
Tamsulosin
Prostate Neoplasm
Menoufia UniversityN/AD (30)
Showing 51 to 70 of 70 assets
PreviousPage 2 of 2Next